top of page

21 November 2025 | Colville, WA

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

11.47 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	11.47
Bid (Size)	11.30 (100)
Ask (Size)	12.78 (100)
Prev. Close	11.47
Today's Range	11.47 - 11.47
52wk Range	9.200 - 14.63
Shares Outstanding	128,489,060
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study ↗

August 21, 2025

Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.

Via Benzinga

Dynavax (DVAX) Q2 Revenue Jumps 29% ↗

August 07, 2025

Via The Motley Fool

Performance

YTD	-11.1%	-11.1%
1 Month	+9.3%	+9.3%
3 Month	+9.9%	+9.9%
6 Month	+17.3%	+17.3%
1 Year	-8.2%	-8.2%

More News

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

June 09, 2025

From Deep Track Capital, LP

Via Business Wire

Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies

June 04, 2025

From Deep Track Capital, LP

Via Business Wire

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) ↗

February 21, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗

September 26, 2025

Via Benzinga

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗

September 22, 2025

Via Benzinga

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Via Benzinga

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday ↗

August 21, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Deep Track Capital Comments on ISS Recommendation

May 23, 2025

From Deep Track Capital, LP

Via Business Wire

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025

From Deep Track Capital, LP

Via Business Wire

Breaking Down Dynavax Technologies: 5 Analysts Share Their Views ↗

May 07, 2025

Via Benzinga

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗

May 07, 2025

Via Benzinga

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 06, 2025

From Deep Track Capital, LP

Via Business Wire

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

April 21, 2025

From Deep Track Capital, LP

Via Business Wire

Where Dynavax Technologies Stands With Analysts ↗

April 17, 2025

Via Benzinga

Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer

April 16, 2025

From Deep Track Capital, LP

Via Business Wire

Evaluating DYNAVAX TECHNOLOGIES CORP (NASDAQ:DVAX) using Mark Minervini’s winning stock formula ↗

March 31, 2025

Via Chartmill

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors

March 10, 2025

From Deep Track Capital, LP

Via Business Wire

Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript ↗

February 20, 2025

Via The Motley Fool

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

February 19, 2025

From Deep Track Capital, LP

Via Business Wire

Frequently Asked Questions

Is Dynavax Technologies Corporation - Common Stock publicly traded?

Yes, Dynavax Technologies Corporation - Common Stock is publicly traded.

What exchange does Dynavax Technologies Corporation - Common Stock trade on?

Dynavax Technologies Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Dynavax Technologies Corporation - Common Stock?

The ticker symbol for Dynavax Technologies Corporation - Common Stock is DVAX on the Nasdaq Stock Market

What is the current price of Dynavax Technologies Corporation - Common Stock?

The current price of Dynavax Technologies Corporation - Common Stock is 11.47

When was Dynavax Technologies Corporation - Common Stock last traded?

The last trade of Dynavax Technologies Corporation - Common Stock was at 11/25/25 04:00 PM ET

What is the market capitalization of Dynavax Technologies Corporation - Common Stock?

The market capitalization of Dynavax Technologies Corporation - Common Stock is 1.47B

How many shares of Dynavax Technologies Corporation - Common Stock are outstanding?

Dynavax Technologies Corporation - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bottom of page